Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Market Cap	49.12M
Revenue (ttm)	29.69M
Net Income (ttm)	4.87M
Shares Out	18.00M
EPS (ttm)	0.27
PE Ratio	10.09
Forward PE	n/a
Dividend	0.06 (2.08%)
Ex-Dividend Date	Apr 30, 2025

Volume	503
Average Volume	4,257
Open	3.850
Previous Close	3.850
Day's Range	3.850 - 3.850
52-Week Range	3.490 - 4.000
Beta	0.12
RSI	55.15
Earnings Date	Aug 10, 2025

About Jerusalem Pharmaceuticals

Jerusalem Pharmaceuticals Co. Ltd. develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally. It offers range of over-the-counter, prescription pharmaceutical, and nutritional supplements products. The company produces approximately 300 pharmaceutical products in various dosage forms, such as tablets, capsules, sterile injectables, suspensions, syrups, powders, suppositories, ovules, creams, ointments, and ear and nose drops, as well as solutions. It also produces detergent, cos...

• Industry: Pharmaceutical Preparations
• Founded: 1969
• Employees: 531
• Stock Exchange: Palestine Stock Exchange
• Ticker Symbol: JPH

Financial Performance

In 2024, Jerusalem Pharmaceuticals's revenue was $39.82 million, an increase of 0.42% compared to the previous year's $39.65 million. Earnings were $5.04 million, a decrease of -27.58%.

Financial numbers in USD